This study aimed to investigate the synergistic effects of OL, a small molecule PARP inhibitor with proven efficacy in preclinical and clinical studies, and GA, a natural polyphenol with potent bioactivity, on OL-resistant human osteosarcoma U2OS cells. Here, PARP1 is linked to osteosarcoma.